5 resultados para enilconazole
Resumo:
Long-term outcomes (mean 38+/-17 months) were evaluated in 27 dogs with sinonasal aspergillosis after successful medical treatment using intranasal infusions of 1% or 2% enilconazole (1%, n=15; 2%, n=12). Long-term outcomes with both treatment protocols were good, with half of the dogs being asymptomatic throughout the follow-up period. The remaining dogs showed mild clinical signs compatible with chronic rhinitis/sinusitis. These clinical signs were interpreted as chronic lymphoplasmacytic rhinitis/sinusitis and episodes of bacterial rather than fungal infection. Three dogs had confirmed reinfection or relapse 2 to 36 months after clinical resolution.
Resumo:
OBJECTIVES To evaluate the effectiveness of rhinotomy and surgical debridement associated with topical administration of 2 per cent enilconazole and oral itraconazole in dogs with severe or recurrent sinonasal aspergillosis. METHODS A standard rhinotomy was performed on seven dogs. In the initial study, the bone flap was left attached cranially and replaced at the end of the procedure. In the main study group, the bone flap was discarded. Nasal passages were debrided and irrigated with enilconazole solution for one hour. Oral itraconazole was administered to four dogs for one month postoperatively. Follow-up rhinoscopy was performed in all dogs. RESULTS All three dogs in the initial study had recurrence of the disease and two dogs had a second surgery to remove the flap. The main study group included four dogs in which the flap was initially removed, and the two dogs from the initial study that required a second surgery. At follow-up rhinoscopy, five dogs were free of aspergillus but had bacterial or inflammatory rhinitis and one dog had a small aspergilloma but was subsequently asymptomatic. Telephone follow-up revealed that four dogs were asymptomatic, one dog had intermittent sneezing and serous nasal discharge, and one dog had intermittent epistaxis. CLINICAL SIGNIFICANCE Rhinotomy with removal of the flap combined with one-hour infusion of 2 per cent enilconazole and oral itraconazole resulted in satisfactory outcome in dogs with severe or recurrent aspergillosis.
Resumo:
Late-season grapefruits (Citrus paradisi Macf. cv. Marsh seedless) were dipped in water at 50°C for 3 min with and without 200 ppm imazalil (IMZ) or 1000 ppm IMZ at 19°C and were subsequently stored at 7°C and 90-95% relative humidity (RH) for 11 weeks plus one week at 21°C and approximately 75% RH to simulate a marketing period (SMP). Residue concentrations in fruit after treatment with 200 ppm IMZ at 50°C were 3.46 ppm, about twice the level (1.80 ppm) found in fruit treated with 1000 ppm IMZ at 19°C. Fungicide degradation rates during storage showed similar patterns resulting in an approximately 50% decrease. Both fungicide treatments significantly reduced decay and chilling injury (CI) during storage and SMP. Hot water reduced CI and decay but not as effectively as the IMZ treatments. Soluble solids concentrations were not affected by treatments, IMZ treatments resulted in significantly lower values of titratable acidity and higher concentrations of ethanol in the juice after SMP. Weight loss was significantly higher in fruit dipped in water at 50°C after SMP. No visible damage occurred to the fruit as a result of any of the treatments.
Resumo:
A rapid and efficient method is described for the determination of thiabendazole and imazalil residues in lemons (peel and pulp). The procedure is based on the extraction with an hexane:ethyl acetate mixture (1:1, v/v) and gas chromatographic analysis using thermionic specific detection (TSD). The possibility of matrix effect was also studied. Mean recoveries from 8 replicates of fortified samples ranged from 79% to 109%, with relative standard deviation values between 2.4% to 12.8%. The detection and quantification limits of the method were 0.2 mg kg-1 and 0.5 mg kg-1, respectively.